Challenges and Opportunity in Eliminating Avoidable Vision Loss in Canada
My Session Status
At the end of this session, participants will be able to:
- Describe the determinants of eye health in Canada
- Describe a practical strategy for optimizing eye health care in Canada
- Identify the trends and impacts of the changing practitioner demographic profile on the ophthalmology workforce
Elementy podrzędne
Authors: Yvonne M. Buys, Tina Felfeli, Mayilee Canizares, Yaping Jin Author Disclosure Block: Y.M. Buys: None. T. Felfeli: None. M. Canizares: None. Y. Jin: None. Abstract Body: Purpose: To investigate the effect of generational and gender differences on practice patterns of Ontario ophthalmologists over the past two decades. Study Design: Age-Period-Cohort (APC) analysis Methods: The Ontario Hea...
Authors: Yaping Jin, William Jeon, Michael Brent, Rick Glazier, Yvonne Buys, Graham Trope Author Disclosure Block: Y. Jin: None. W. Jeon: None. M. Brent: Grant/research support; Name of Commercial Company(s); Novartis and Bayer. Membership on an advisory panel, standing committee or board of directors; Name of Commercial Company(s); Novartis, Bayer, and Allergan. R. Glazier: None. Y. Buys: None. G. Trope: None. Abs...
Authors: Kiersten Schock, Alex Ragan, John T. Huang Author Disclosure Block: K. Schock: None. A. Ragan: None. J.T. Huang: None. Abstract Body: Purpose: Several health authorities within Canada have recently decided to defund the routine pre-operative history and physical exam traditionally performed prior to cataract surgery. While these authorities suggest that their decisions are evidence based, the authors are not aware of any com...
Authors: Ellen E. Freeman, Rumaisa Aljied, Marie-Josée Aubin, Saama Sabeti, Ralf Buhrmann Author Disclosure Block: E.E. Freeman: None. R. Aljied: None. M. Aubin: Grant/research support; Name of Commercial Company(s); AbbVie. Membership on an advisory panel, standing committee or board of directors; Name of Commercial Company(s); AbbVie. S. Sabeti: None. R. Buhrmann: Employment/honoraria/consulting fees; Name of Commercial Company(s); Allergan. Abst...
Authors: Ian Wong, Raymond Wong, Rita Gangwani, Jonathan Chan, Ryo Kawasaki, Victor Chong Author Disclosure Block: I. Wong: None. R. Wong: None. R. Gangwani: None. J. Chan: None. R. Kawasaki: None. V. Chong: None. Abstract Body: Purpose: To compare the cost-effectiveness of four different screening strategies to detect diabetic macular edema Study Design: Subjects are recruited from a local screening program duri...
Authors: Carl Shen, Michael Nguyen, Alexander Gregor, Gloria Isaza, Anne Beattie Author Disclosure Block: C. Shen: None. M. Nguyen: None. A. Gregor: None. G. Isaza: None. A. Beattie: None. Abstract Body: Purpose: To evaluate the diagnostic accuracy, triage urgency, and interuser variability of a popular online symptom checker for common ophthalmic presentations Study Design: Cross-sectional descriptive study ...
Authors: Matthew B. Schlenker, Deva Thiruchelvam, Don Redelmeier Author Disclosure Block: M.B. Schlenker: Employment/honoraria/consulting fees; Name of Commercial Company(s); Allergan, Alcon, AMO, Light Matter Interaction. D. Thiruchelvam: None. D. Redelmeier: None. Abstract Body: Purpose: Cataracts are the most common cause of visual impairment worldwide and may increase the risk of a serious traffic crash. The potential benefits of...
